Skip to content

4Accepted Oct 19, 4:19 PM ET

CLOVER HEALTH INVESTMENTS, CORP.: CEO Jamie L. Reynoso sold 18,273 shares

CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE

Accepted (ET)

4:19 PM

Oct 19, 2026

Filed

Oct 19, 2026

Documents

1

Size

6.4 KB

Summary

CLOVER HEALTH INVESTMENTS, CORP.: CEO Jamie L. Reynoso sold 18,273 shares

Updated

What happened

  • Jamie L. Reynoso, CEO, Medicare Advantage, sold 18,273 shares in an open market or private sale (code S) on Oct 15, 2026. The filing reports a weighted average price of $4.68 and total proceeds of $85,518.

Key details

  • Transaction date and price: Oct 15, 2026; weighted average $4.68; prices ranged from $4.67 to $4.68 per the filing (footnote 2).
  • Shares owned after the transaction: not reported on this Form 4.
  • Footnotes: (1) The shares sold were required to be sold to cover tax withholding for the quarterly vesting on Oct 15, 2026 of 6.25% of restricted stock units granted Oct 15, 2024; the RSUs vest quarterly with final vesting on Oct 15, 2028, subject to continued service. The sales were mandated by the issuer's "sell to cover" election and do not represent discretionary trades by the reporting person. (2) The reported price is a weighted average; the reporting person can provide a breakdown of the number of shares sold at each separate price on request.
  • Filing date vs. transaction date: Form filed Oct 19, 2026 reporting the Oct 15, 2026 transaction. The filing itself does not indicate that it was late.

Why it may matter

  • This was a sell-to-cover tax withholding sale tied to RSU vesting, not an independently elected sale per the filing.
  • The filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing